Gel Manufacturing: SOP for Conducting Photostability Testing for Gels – V 2.0
Standard Operating Procedure for Conducting Photostability Testing on Gel Formulations
| Department |
Gel Manufacturing |
| SOP No. |
SOP/GM/109/2025 |
| Supersedes |
SOP/GM/109/2022 |
| Page No. |
Page 1 of 12 |
| Issue Date |
02/06/2025 |
| Effective Date |
04/06/2025 |
| Review Date |
02/06/2027 |
1. Purpose
To describe the procedure for performing photostability testing on gel formulations in accordance with ICH Q1B guidelines to determine the light sensitivity and stability profile of the product.
2. Scope
This procedure applies to all new and existing pharmaceutical gel products manufactured in the facility that require photostability testing for regulatory submission
or product development purposes.
3. Responsibilities
- Stability Analyst: Prepares and exposes samples under defined conditions.
- Quality Control (QC): Performs analysis of photostressed samples.
- Quality Assurance (QA): Reviews and approves the test plan and outcome.
- R&D/Formulation Development: Evaluates the formulation impact in case of degradation.
4. Accountability
Head – Quality Assurance is accountable for ensuring compliance with regulatory guidelines and proper execution of photostability testing procedures.
5. Procedure
5.1 Preparation
- Obtain representative samples of the gel product in its market pack and container-closure system.
- Label each sample clearly with batch number, exposure date, and time.
- Place the control (dark) sample and exposed sample in different containers for comparison.
5.2 Exposure Conditions
- Use a validated photostability chamber that complies with ICH Q1B Option 2 (fluorescent and near UV lamps).
- Ensure exposure to a minimum of 1.2 million lux hours and 200 watt-hours/m² of near UV energy.
- Maintain chamber temperature between 25°C to 30°C.
5.3 Sample Placement
- Place exposed samples evenly on a rotating platform within the chamber to ensure uniform exposure.
- Wrap the control samples in aluminum foil or place in a light-opaque container.
5.4 Duration and Monitoring
- Expose samples for a period sufficient to reach the specified lux and UV exposure levels.
- Monitor and document lux and UV levels using calibrated sensors at set intervals.
5.5 Evaluation of Samples
- After exposure, retrieve the samples and store at ambient conditions until analysis.
- Perform visual inspection for discoloration, phase separation, and turbidity.
- Conduct chemical tests for assay, degradation products, pH, and viscosity using validated methods.
5.6 Documentation and Reporting
- Document all test data in the Photostability Testing Log (Annexure-1).
- Prepare the Photostability Test Summary Report (Annexure-2).
- Submit findings to QA for review and sign-off.
6. Abbreviations
- QA: Quality Assurance
- QC: Quality Control
- ICH: International Council for Harmonisation
- UV: Ultraviolet
- Lux: Unit of illumination
7. Documents
- Photostability Protocol – Annexure-1
- Photostability Summary Report – Annexure-2
- Chamber Qualification Record
8. References
- ICH Q1B: Photostability Testing of New Drug Substances and Products
- WHO Technical Report Series No. 1010
- PharmaSOP – Stability Testing SOP
9. SOP Version
Version: 2.0
10. Approval Section
|
Prepared By |
Checked By |
Approved By |
| Signature |
|
|
|
| Date |
|
|
|
| Name |
|
|
|
| Designation |
Jr. Production Chemist |
QA Executive |
Head – Manufacturing |
| Department |
Gel Manufacturing |
Quality Assurance |
Manufacturing |
11. Annexures
Annexure-1: Photostability Testing Log
| Batch No. |
|
| Exposure Start Date |
|
| Exposure End Date |
|
| Exposure Conditions |
Lux: __________ | UV: __________ |
| Temperature (°C) |
|
| Visual Appearance |
|
| Remarks |
|
Annexure-2: Photostability Test Summary Report
| Test Parameter |
Initial Result |
Post-Exposure Result |
Limit |
Conclusion |
| Assay (%) |
|
|
|
|
| Degradation Products (%) |
|
|
|
|
| pH |
|
|
|
|
| Viscosity (cP) |
|
|
|
|
Revision History
| Revision Date |
Revision No. |
Change Description |
Reason |
Approved By |
| 16/05/2022 |
1.0 |
Initial Issue |
New SOP |
QA Head |
| 02/06/2025 |
2.0 |
Aligned with ICH Q1B Option 2 and added annexures |
Regulatory Compliance |
QA Head |